Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples